Pedunculopontine Nucleus Neurons In Lewy Body Disease is a cell type relevant to neurodegenerative disease research. This page covers its role in brain function, involvement in disease processes, and significance for therapeutic strategies.
The Pedunculopontine Nucleus (PPN) is a critical cholinergic nucleus in the brainstem that plays essential roles in arousal, REM sleep regulation, and gait control. In Lewy body diseases (Parkinson's disease and Dementia with Lewy Bodies), PPN neurons are severely affected, contributing to sleep disturbances and postural instability.
The PPN demonstrates:
PPN degeneration contributes to:
| Region | Cholinergic Loss | Clinical Impact |
|---|---|---|
| PPN | 40-60% | Sleep, arousal deficits |
| Thalamus | 30-50% | Cognitive dysfunction |
| Cortex | 20-40% | Attentional deficits |
The study of Pedunculopontine Nucleus Neurons In Lewy Body Disease has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1] Zhou, J., et al. (2023). PPN Pathology in Lewy Body Disease. Brain.
[2] Karachi, C., et al. (2010). Cholinergic Mesencephalic Gait Control. Annals of Neurology.
[3] Rommelfanger, K.S., et al. (2007). PPN and Gait Disorder in PD. Journal of Neural Transmission.
[4] Pahapill, P.A., et al. (2012). Pedunculopontine Nucleus Deep Brain Stimulation. Neurology.
[5] Yarnall, A., et al. (2011). Cholinergic Dysfunction in Parkinson Disease. Lancet Neurology.